Hypertrophic pachymeningitis with anti‐neutrophil cytoplasmic antibody (p‐ANCA), and diabetes insipidus

We treated a patient with idiopathic cranial hypertrophic pachymeningitis and elevated serum titer of perinuclear anti‐neutrophil cytoplasmic antibody (p‐ANCA) reactive against myeloperoxidase. This 67‐year‐old man showed multiple cranial nerve‐palsies, central diabetes insipidus (DI), and an intrasellar mass. DI and intrasellar mass had been present for 3 years, and DI had been well controlled by intranasal desmopressin. His nerve‐palsies were most likely caused by thickened dura matter detected by the brain MRI. Granuloma may develop in the sella, and MRI findings in our patient are compatible to it. Corticosteroid and oral cyclophosphamide therapy improved his neurological symptoms and serum p‐ANCA level with showing good correlation. DI improved temporally for 2 months. Few other cases of hypertrophic pachymeningitis with elevated p‐ANCA have been reported, however the etiology is unknown. As p‐ANCA antibodies have been detected in many of vasculitides, microvasculitis may be involved in some cases of idiopathic hypertrophic pachymeningitis.

[1]  T. Itoh,et al.  P‐ANCA‐positive Wegener’s granulomatosis presenting with hypertrophic pachymeningitis and multiple cranial neuropathies: Case report and review of literature , 2000, Neuropathology : official journal of the Japanese Society of Neuropathology.

[2]  Y. Lo,et al.  Hypertrophic cranial pachymeningitis and lymphocytic hypophysitis in Sjögren’s syndrome , 1999, Neurology.

[3]  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 9-1999. A 75-year-old woman with hydrocephalus and pleocytosis. , 1999, The New England journal of medicine.

[4]  S. Kobayashi,et al.  Pachymeningitis with a perinuclear antineutrophil cytoplasmic antibody: Response to pulse steroid , 1998, Neurology.

[5]  Dong Ik Kim,et al.  Idiopathic Hypertrophic Pachymeningeal Lesions , 1998, European Neurology.

[6]  O. Bang,et al.  Idiopathic hypertrophic pachymeningeal lesions: correlation between clinical patterns and neuroimaging characteristics. , 1998, European neurology.

[7]  K. Shindo,et al.  [Idiopathic hypertrophic cranial pachymeningitis associated with Horner's syndrome. A case report]. , 1997, Rinshō shinkeigaku Clinical neurology.

[8]  R. Falk,et al.  Clinical and pathological classification of ANCA‐associated vasculitis: what are the controversies? , 1995, Clinical and experimental immunology.

[9]  Y. Narita,et al.  [A case of optic neuropathy, recurrent transverse myelopathy and hypertrophic pachymeningitis associated with perinuclear anti-neutrophil cytoplasmic antibodies (p-ANCA)]. , 1995, Rinshō shinkeigaku Clinical neurology.

[10]  I. Maruyama,et al.  [Case of hypertrophic meningitis with vasculitis syndrome]. , 1994, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.

[11]  Tadahiko Shikakura A case of hyperplasic pachymeningitis in which vasculitis syndrome was suspected. , 1994 .

[12]  R. Goldschmeding,et al.  Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy , 1993, The Lancet.

[13]  E. Csernok,et al.  ANCA and associated diseases: immunodiagnostic and pathogenetic aspects , 1993, Clinical and experimental immunology.

[14]  C. Kallenberg,et al.  Antineutrophil cytoplasmic antibodies: a still-growing class of autoantibodies in inflammatory disorders. , 1992, The American journal of medicine.

[15]  J. Kucharczyk,et al.  MR imaging of the brain in patients with diabetes insipidus. , 1991, AJNR. American journal of neuroradiology.